Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Post by retiredcopon May 31, 2018 2:13pm
93 Views
Post# 28106913

More reports

More reports

Global Superoxide Dismutase Market Share 2018 – Voyager Therapeutics, RXi Pharmaceuticals Corporation, ProMIS Neurosciences and Neurimmune Holding AG

 

The research report “Global Superoxide Dismutase Market Analysis 2013 – 2017 and Forecast 2018 – 2025” presents market key insights for investors and other key stakeholders to assess the global superoxide dismutase market. The performance of the superoxide dismutase market evaluated in terms of value USD Million over the period 2018 to 2025. The study shows current market trends, the scope of various segments in superoxide dismutase market, latest market developments and opportunities for newcomers or established players of superoxide dismutase market. Market players that are cited in the report Neurimmune Holding AG, Voyager Therapeutics, RXi Pharmaceuticals Corporation, Ionis Pharmaceuticals and ProMIS Neurosciences.

The report begins with an executive summary contains market statistics and scope of global superoxide dismutase market segments from the forecast period 2018 to 2025. In the next section, the report adds a study of superoxide dismutase market dynamics includes business growth factors and restrainers, emerging countries and growing market for superoxide dismutase, industry news and policies according to regions, threats, challenges and opportunities available in superoxide dismutase market.

Try free sample report, click here: https://market.biz/report/global-superoxide-dismutase-market-hr/200250/#requestforsample

Furthermore, this report analyzes various business channels and development technology. Most importantly, an in-depth analysis related to the industrial background to investigate the marketing impact and to understand how to pull the industry to a higher level in the competitive market. The global market for superoxide dismutase is anticipated to reach X.X million USD in 2018 with CAGR of XX% from 2018 to 2025.

Competitive Landscape and Market Segmentation 

To define competitive nature of the global superoxide dismutase market report highlight the prominent market players with detail company profile based on SWOT examination. Moreover, company recent market developments, market shares, merger and acquisition with other prominent establishments, financial deals which impact the market in recent years are identified. In addition, company long term and short term strategies added to a report to analyze future market developments and approaches towards the superoxide dismutase market.

The next market segmentation breaks down the superoxide dismutase market into product types, end-user applications, regional scope. Here the performance of individual segment in superoxide dismutase market is calculated. The regional and country level breakdown of global superoxide dismutase market give size and analysis of the market in each geography by comparing historic and forecast growth. Furthermore, the report presents comparison based on country populations and growing economies for superoxide dismutase.


Bullboard Posts